The global Cellbag Bioreactor Chambers market is entering a period of transformative growth, with market value projected to ...
The biopharmaceutical and biotech industries face mounting challenges in regulated environments, including rising drug development costs, strict regulatory demands, and the need for scalable, ...
WuXi Biologics completed the first commercial project Process Performance Qualification (PPQ) campaign for its three sets of 5,000 L single-use bioreactors (SUBs) in the second drug substance line of ...
Thermo Fisher introduced the 5 L DynaDrive Single-Use Bioreactor (S.U.B.) that expands the company’s portfolio of bioreactors, offering scalability from 1 to 5,000 liters and targeting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results